| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |